Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Polyprotic Acids03:38

Polyprotic Acids

Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model Is Crucial.

Clinical and translational science·2026
Same author

The Placebo Effect in Rare Disease Clinical Trials: Measurement, Impact, and Statistical Approaches for Patient-as-Own-Control Designs.

Clinical and translational science·2026
Same author

Propionic acidemia and methylmalonic aciduria: A portrait of the first 3 years-Admissions and complications.

Molecular genetics and metabolism·2025
Same author

Infantile Spasms in Inborn Errors of Metabolism: Diagnostic and Therapeutic Considerations.

Journal of child neurology·2025
Same author

Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome associated with alteration of metabolic signaling.

American journal of human genetics·2025
Same author

Pathogenic variants in <i>TMEM184B</i> cause a neurodevelopmental syndrome associated with alteration of metabolic signaling.

medRxiv : the preprint server for health sciences·2024
Same journal

Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX).

Molecular genetics and metabolism·2026
Same journal

Participants with long-chain 3-hydroxy-acylCoA dehydrogenase deficiency (LCHADD)/trifunctional protein deficiency (TFPD) report consistent low-fat diet intake over time.

Molecular genetics and metabolism·2026
Same journal

Expanding the clinical and molecular spectrum of NGLY1 deficiency: A multicenter cohort.

Molecular genetics and metabolism·2026
Same journal

Driving treatment for females with X-linked adrenoleukodystrophy.

Molecular genetics and metabolism·2026
Same journal

High dietary fat causes muscle structural breakdown, mitochondrial dysfunction, and contractile deficits in the absence of carnitine palmitoyltransferase 2.

Molecular genetics and metabolism·2026
Same journal

Ketogenic diet therapy in pyruvate dehydrogenase deficiency: Global clinical practice from literature and survey data.

Molecular genetics and metabolism·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

Propionic acidemia consensus conference summary.

Kimberly A Chapman1, Marshall L Summar

  • 1Children's National Medical Center, Washington, DC 20010, USA. kchapman@childrensnational.org

Molecular Genetics and Metabolism
|September 13, 2011
PubMed
Summary
This summary is machine-generated.

Propionic acidemia diagnosis and management guidelines were developed at a 2011 consensus conference. This issue presents recommendations for acute and chronic care, disease natural history, and neurological complications.

More Related Videos

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid
04:10

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

Published on: March 8, 2024

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

Related Experiment Videos

Last Updated: May 29, 2026

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid
04:10

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

Published on: March 8, 2024

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Medicine

Background:

  • A consensus conference was convened in January 2011 at Children's National Medical Center to address the diagnosis and management of propionic acidemia.
  • This conference brought together experts to establish standardized recommendations for this rare metabolic disorder.

Discussion:

  • The conference addressed critical aspects of propionic acidemia care, including acute metabolic decompensations and long-term health monitoring.
  • Management strategies for chronic care were discussed, emphasizing the need for ongoing surveillance and intervention.

Key Insights:

  • Recommendations for the acute management of metabolic decompensations in propionic acidemia were formulated.
  • Guidelines for the chronic management and health monitoring of patients were established, focusing on proactive care.
  • The natural history of propionic acidemia was reviewed, providing insights into disease progression.
  • Neurologic complications associated with propionic acidemia were a key focus, highlighting their significance.

Outlook:

  • This collection of manuscripts provides a comprehensive resource for clinicians managing propionic acidemia.
  • The established recommendations aim to improve patient outcomes and quality of life.
  • Future research directions may emerge from the insights gained into the natural history and complications of the disease.